Laffer Tengler Investments’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Laffer Tengler Investments’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-15	Closed	-$2	–	494
2022 Q3	$2	Hold	15	–	–	﹤0.01%	432
2022 Q2	$16	Hold	15	–	–	﹤0.01%	389
2022 Q1	$78	Hold	15	–	–	﹤0.01%	415
2021 Q4	$86	Hold	15	–	–	﹤0.01%	382
2021 Q3	$169	Buy	+15	New	+$188	﹤0.01%	480

Laffer Tengler Investments's EVFM Position: Q4 2022 in Review

Laffer Tengler Investments sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q4 2022, closing a stake of 15 shares — an estimated $2 sold.

Laffer Tengler Investments first reported a position in EVFM in Q3 2021 and held it in 5 quarters. The position peaked at $169 in Q3 2021. 0 funds tracked by Wall St. Rank hold EVFM as of Q4 2022.

Laffer Tengler Investments reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Laffer Tengler Investments sold 15 Evofem Biosciences, Inc. Common Stock shares in Q4 2022, an estimated $2.
Laffer Tengler Investments first reported a position in Evofem Biosciences, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
Laffer Tengler Investments's Evofem Biosciences, Inc. Common Stock position peaked at $169 in Q3 2021.
0 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q4 2022.

Based on Laffer Tengler Investments's 13F filing for Q4 2022, filed 10 Feb 2023.